olezarsen TGs
Selected indexed studies
- Triglyceride Lowering Drugs. (, 2000) [PMID:28402615]
- Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. (Am Heart J, 2025) [PMID:40064331]
- Efficacy and safety of antisense oligonucleotide therapies targeting APoC-III in patients with severe hypertriglyceridemia: a meta-analysis of randomized controlled trials. (Monaldi Arch Chest Dis, 2026) [PMID:41755797]
_Worker-drafted node — pending editorial review._
Connections
olezarsen TGs is a side effect of
Sources
- Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. (2025) pubmed
- Triglyceride Lowering Drugs. (2000) pubmed
- Efficacy and safety of antisense oligonucleotide therapies targeting APoC-III in patients with severe hypertriglyceridemia: a meta-analysis of randomized controlled trials. (2026) pubmed
- An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome. (2026) pubmed